Assessing small fiber neuropathy in fibromyalgia patients
Official title: Fibromyalgia and Small Fiber Neuropathy : Which Prevalence and Which Relationship With Pain ?
Run by Hospital Ambroise Paré Paris · NCT06527183 · Data updated 2026-11-12
This study is trying to see how common small fiber nerve damage is in people with fibromyalgia compared to those with other chronic pain conditions and healthy individuals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Hospital Ambroise Paré Paris Academic / other |
| Locations | 2 sites (Boulogne-Billancourt and 1 other locations) |
| Status | Recruiting |
| Started | January 4, 2022 |
| Main results expected | December 2025 |
| Study ends | May 2026 |
| Registry record updated | September 10, 2025 |
| Trial ID | NCT06527183 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 years old suffering from chronic pain for at least six months, with a diagnosis of fibromyalgia or other chronic pain conditions.
✕Probably not a fit
Patients with known causes of small-fiber neuropathy, such as diabetes, or those seeking litigation or compensation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the prevalence of diffuse small-fiber neuropathy in patients with fibromyalgia and compare it to individuals with other types of chronic pain and healthy controls. It will utilize skin biopsies to identify structural abnormalities in small nerve fibers, alongside functional assessments using validated tests such as quantitative sensory testing and laser evoked potential recordings. The goal is to determine if patients with small fiber neuropathy exhibit distinct clinical profiles regarding pain, physical activity, and comorbidities. This observational study will provide insights into the relationship between small fiber neuropathy and fibromyalgia symptoms.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and management of fibromyalgia and related chronic pain conditions.
How similar studies have gone: While small fiber neuropathy has been observed in fibromyalgia patients, this specific approach to assessing its prevalence and clinical implications is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients over 18 years of age with no age limit - * having given their signed consent to take part in the study * affiliated to the French social security system * able to be followed for the entire duration of the study * reading and understanding French * accepting the principle of the study and able to comply with its conditions * suffering from chronic pain for at least six months of at least moderate intensity (≥ 4/10) * fibromyalgia detected by the FiRST questionnare and defined by the revised diagnostic criteria of the WHO or chronic nociceptive or nociplastic pain without associated fibromyalgia. * chronic pain for at least 6 months of at least moderate intensity (≥ 4/10) * untreated or with stable analgesic treatment for at least 2 weeks prior to inclusion- normal neurological examination at inclusion Exclusion Criteria: * litigation or compensation-seeking * cancer for less than 2 years * known cause of small-fiber neuropathy such as diabetes, systemic disease, hypothyroidism, alcohol, renal failure, genetic disease * clinical or EMG neuropathy * peripheral or central nervous system pathology with or without associated neuropathic pain * uncontrolled chronic pathology such as : morbid obesity, sleep apnea, uncontrolled hypertension, etc. - psychosis, previous suicide attempt * drug or psychoactive substance abuse * cognitive or psychological disorders incompatible with compliance with and/or understanding of the protocol * participation in another biomedical research protocol.
Where it's running
-
Inserm U987
Boulogne-Billancourt, France Recruiting -
Centre d'Evaluation et de Traitement de la douleur
Paris, France Recruiting
Study contacts
- Principal investigator: Nadine ATTAL, MD PhD — Aphp
- Study coordinator: Nadine ATTAL, MD PhD
- Email: nadine.attal@aphp.fr
- Phone: 0033149095931
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tracking outcomes of intravenous lidocaine for chronic pain
This study tests how well IV lidocaine infusions work for people with chronic pain who are already prescribed the treatment.
-
Cryoneurolysis for Chronic Pain: 6- and 12-Month Outcomes in Routine Care
This study tests whether cryoneurolysis, done as part of standard care for people with chronic pain, leads to meaningful improvements over 6 to 12 months.
-
Therapeutic yoga and interoceptive awareness in adolescents with chronic pain
This will test whether an occupational therapy plan that includes therapeutic yoga helps adolescents (ages 11–21) with chronic pain improve body awareness and day-to-day function.
-
Assessing different rTMS protocols for treating neuropathic pain
This study is testing three different types of brain stimulation to see which one helps people with chronic nerve pain feel better.
-
Shiatsu therapy for long-lasting non-inflammatory pain in children and teens
This study will try weekly 30-minute Shiatsu sessions alongside regular care to see if they improve quality of life for children and adolescents (ages 10–18) with non-inflammatory chronic pain.
-
Mind-body approach for treating chronic upper extremity pain
This study is testing a mind-body program to see if it can help people with chronic upper arm and hand pain feel better and improve how well they can use their arms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.